← Back to Search

Behavioural Intervention

Ankle Splint Stretching for Peripheral Arterial Disease

N/A
Recruiting
Led By Judy Delp, PhD
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial is testing whether or not stretching can improve symptoms for people with peripheral arterial disease.

Who is the study for?
This trial is for people over 40 with stable Peripheral Arterial Disease (PAD) for at least 3 months and an ankle-brachial index of 0.90 or less. It's not suitable for those with limited joint motion, oxygen needs during exercise, regular exercisers, recent cardiovascular rehab participants, amputees, critical limb ischemia sufferers, rest leg pain patients, cardiorespiratory disease or diabetes sufferers, recent major illness treatments or surgeries.Check my eligibility
What is being tested?
The study tests if static muscle stretching using ankle splints can improve muscle oxygenation and walking ability in PAD patients. In this single-blinded study involving 40 participants over four weeks, one group will perform active stretching while the control group wears the splint without stretching.See study design
What are the potential side effects?
While specific side effects are not listed in the provided information about this clinical trial on static muscular stretching using ankle splints for PAD treatment; typically such non-invasive interventions may cause discomfort or minor pain due to stretching.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Continuous Walking Distance
Change in Muscle Oxygenation
Change in Total Walking Distance

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Stretch GroupExperimental Treatment1 Intervention
Subjects assigned to this group will be instructed on how to wear the device to produce the appropriate amount of dorsiflexion (stretch). Splint devices will be worn at the assigned angle 5 days/week, 30 minutes/day, for 4 weeks. ABI, muscle oxygenation, and walking distance will be assessed pre/post stretching. Other health surveys will be administered.
Group II: No Stretch GroupPlacebo Group1 Intervention
Subjects assigned to this group will wear the splints but instructed to wear the device in a position that produces no stretch. Splint devices will be worn at the assigned angle 5 days/week, 30 minutes/day, for 4 weeks. ABI, muscle oxygenation, and walking distance will be assessed pre/post stretching. Other health surveys will be administered.

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
199 Previous Clinical Trials
31,651 Total Patients Enrolled
2 Trials studying Peripheral Arterial Disease
26 Patients Enrolled for Peripheral Arterial Disease
Mayo ClinicOTHER
3,207 Previous Clinical Trials
3,767,100 Total Patients Enrolled
4 Trials studying Peripheral Arterial Disease
240 Patients Enrolled for Peripheral Arterial Disease
Judy Delp, PhDPrincipal Investigator - Florida State University, College of Medicine
Florida State University

Media Library

Static Muscular Stretching (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04222751 — N/A
Peripheral Arterial Disease Research Study Groups: Stretch Group, No Stretch Group
Peripheral Arterial Disease Clinical Trial 2023: Static Muscular Stretching Highlights & Side Effects. Trial Name: NCT04222751 — N/A
Static Muscular Stretching (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04222751 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is my profile compatible with the conditions of this medical study?

"Those suffering from peripheral arterial disease (PAD) between the ages of 40 and 100 are eligible to apply for this clinical trial. A total of 40 participants will be subsequently accepted into the program."

Answered by AI

To what degree is the capacity of this trial being utilized?

"Affirmative, clinicaltrials.gov indicates that this research endeavour is presently accepting participants. It was first made available to the public on July 29th 2020 and was modified as recently as March 16th 2022. There are 40 slots open across one medical centre."

Answered by AI

Is this research project open to participants aged 55 and older?

"This clinical study is searching for candidates aged between 40 and 100 years old."

Answered by AI

Is this experiment currently seeking participants?

"The clinical trial is actively seeking volunteers, with the initial post date being July 29th 2020 and most recent edit being March 16th 2022. Such information can be found on clinicaltrials.gov."

Answered by AI
~9 spots leftby Apr 2025